SPC3 is a multibranched peptide containing eight identical GPGRAF motifs wh
ich are derived from the human immunodeficiency virus (HIV)-1 gp120 V3 loop
consensus sequence. This molecule was reported to prevent the infection of
CD4(+) cells by various HIV-1 and HIV-2 strains. However, the molecular mo
de of action of SPC3 remains unclear. Here, we investigated the possibility
that SPC3 could interact with alpha/beta -chemokine receptors following ob
servations that, first, the V3 loop is likely to be involved in alpha/beta
-chemokine receptor-dependent HIV entry and, second, natural ligands of the
se receptors are potent inhibitors of cell infection. To address this point
, we examined the effects of SPC3 on Xenopus oocytes either uninjected or e
xpressing exogenous human CXCR4 alpha -chemokine receptors. Extracellular a
pplications of micromolar concentrations of SPC3 onto Xenopus oocytes trigg
er potent inward chloride currents which can be inhibited by increasing ext
racellular Ca2+ concentration. This effect can be blocked by chloride chann
el antagonists and is highly specific to SPC3 as it is not triggered by str
uctural analogs of SPC3. The SPC3-induced chloride conductance in oocytes i
s alpha/beta -chemokine receptor dependent because: (i) SPC3 alters the sen
sitivity of this channel to external applications of human recombinant MIP-
ls a natural ligand of human CCR5 receptor, and (ii) the amplitude of the i
nward current could be increased by the expression of exogenous human CXCR4
chemokine receptor. The effect of SPC3 appears to rely on the activation o
f a phospholipase Az signaling pathway, but is not affected by changes in c
ytosolic Ca2+ concentration, or by alterations in Gi/Go protein, adenylate
cyclase, phospholipase C or protein kinase C activity. Altogether, the data
indicate that SPC3 is capable of activating a surface alpha/beta -chemokin
e-like receptor-mediated signaling pathway in competent cells, thereby trig
gering, either directly or indirectly, a Ca2+-inactivated chloride conducta
nce.